胸外科手术后继发乳糜胸的防治

doi:10.3969/j.issn.1009-976X.2021.06.021

摘要/Abstract

摘要： 乳糜胸是一种罕见且严重的胸外科手术并发症,导致患者严重的营养消耗、生理紊乱和免疫抑制,了解乳糜漏的病理生理学是治疗原则的基础。保守治疗旨在通过营养干预减少乳糜的产生,并通过乳糜液引流控制症状,终点是淋巴管的自发闭合。手术干预的时机仍然存在争议,胸腔镜胸导管夹闭以及栓塞已成为开放手术的替代方案。采取何种处理方法应根据患者自生情况判断和决定,过度强调手术及不适当的保守治疗都不是临床的最佳选择。本文对胸外科术后继发乳糜胸的治疗及预防现状和新的进展进行了综述。

关键词: 术后并发症, 乳糜胸, 保守治疗, 手术治疗, 预防

Abstract: Chylothorax is a rare and serious complication after thoracic surgery, leading to severe nutritional consumption, physiological disorders and immunosuppression in patients. Understanding the pathophysiology of chylothorax is the basis of the management principle for chylothorax. Conservative treatment aims to reduce the production of chyle through nutritional intervention, and to control symptoms through chyle drainage, with the end point being the spontaneous closure of lymphatic vessels. The timing of surgical intervention is still controversial, and either ligation or embolization of thoracic ducthave become an alternative to open surgery. The treatment method to be adopted should be judged and decided according to the patient's own condition. Overemphasis on surgery and inappropriate conservative treatment are not the best clinical choice. This article only reviews the current status and new developments in the treatment and prevention of secondary chylothorax after thoracic surgery.

Key words: postoperative complication, chylothorax, conservative treatment, surgical treatment, prevention

中图分类号:

R655.8

吴卓鹏, 杨劼. 胸外科手术后继发乳糜胸的防治[J]. 岭南现代临床外科, 2021, 21(06): 688-692.

WU Zhuo-peng, YANG Jie. Prevention and treatment of chylothorax in thoracic surgery[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 688-692.

参考文献

[1] Riley LE, Ataya A.Clinical approach and review of causes of a chylothorax[J]. Respir Med, 2019, 157: 7-13.
[2] Bryant AS, Minnich DJ, Wei B, et al.The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection[J]. Ann Thorac Surg, 2014, 98(1):232-235.
[3] Liu CY, Hsu PK, Huang CS, et al.Chylothorax complicating video-assisted thoracoscopic surgery for non-small cell lung cancer[J]. World J Surg, 2014, 38(11):2875-2881.
[4] Petrella F, Casiraghi M, Radice D, et al.Treatment of Chylothorax after Lung Resection: Indications, Timing, and Outcomes[J]. Thorac Cardiovasc Surg, 2020, 68(6): 520-524.
[5] Lv S, Wang Q, Zhao W, et al.A review of the postoperative lymphatic leakage[J]. Oncotarget, 2017, 8(40): 69062-69075.
[6] Agrawal V, Doelken P, Sahn SA.Pleural fluid analysis in chylous pleural effusion[J]. Chest, 2008, 133(6): 1436-1441.
[7] Merrigan BA, Winter DC, O'Sullivan GC. Chylothorax[J]. Br J Surg, 1997, 84(1):15-20.
[8] Kiyonaga M, Mori H, Matsumoto S, et al.Thoracic duct and cisterna chyli: evaluation with multidetector row CT[J]. Br J Radiol, 2012, 85(1016): 1052-1058.
[9] Phang K, Bowman M, Phillips A, Windsor J.Review of thoracic duct anatomical variations and clinical implications[J]. Clin Anat, 2014, 27(4): 637-644.
[10] Agrawal V, Doelken P, Sahn SA.Pleural fluid analysis in chylous pleural effusion[J]. Chest, 2008, 133(6): 1436-1441.
[11] Romero S.Nontraumatic chylothorax[J]. Curr Opin Pulm Med, 2000, 6(4): 287-291.
[12] Maldonado F, Hawkins FJ, Daniels CE, et al.Pleural fluid characteristics of chylothorax[J]. Mayo Clin Proc, 2009, 84(2): 129-133.
[13] Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH. Etiology of chylothorax in 203 patients[J]. Mayo Clin Proc, 2005, 80(7): 867-870.
[14] Hooper C, Lee YC, Maskell N. BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline2010 [J]. Thorax, 2010, 65(Suppl 2): ii4-17.
[15] Misthos P, Kanakis MA, Lioulias AG.Chylothorax complicating thoracic surgery: conservative or early surgical management?[J]. Updates Surg, 2012, 64(1): 5-11.
[16] Falode O, Hunt I, Young CP.Chylothorax after coronary artery bypass surgery[J]. J R Soc Med, 2005, 98(7): 314-315.
[27] Elsayed S, Gohar A, Jamous F.Brief review of chylothorax diagnosis and management: making the case for substance over appearance[J]. S D Med, 2021, 74(9): 434-439.
[28] Christodoulou M, Ris HB, Pezezetta E.Video-assisted right supradiaphragmatic thoracic duct ligation for non-traumatic recurrent chylothorax[J]. Eur J Cardiothorac Surg, 2006, 29(5): 810-814.
[29] Scott KJ, Simko E.Thoracoscopic management of cervical thoracic duct injuries: an alternative approach[J]. Otolaryngol Head Neck Surg, 2003, 128(5): 755-757.
[30] 杨劼, 王俊, 古卫权, 等.电视胸腔镜胸导管夹闭术对高脂血症影响的初步研究[J]. 中华胸心血管外科杂志, 2015, 31(9): 541-544.
[31] Lai FC, Chen L, Tu YR, et al.Prevention of chylothorax complicating extensive esophageal resection by mass ligation of thoracic duct: a random control study[J]. Ann Thorac Surg, 2011, 91(6): 1770-1774.
[32] 陈钦谕, 张靖. 乳糜瘘介入诊疗的研究进展[J/CD]. 中华介入放射学电子杂志, 2020, 8(3): 264-268.
[33] Novelli PM, Chan EG, Frazier AA, Villa Sanchez M.Interventional Therapies for Thoracic Duct Injury and Intractable Chylothorax[J]. J Thorac Imaging, 2019, 34(4): 258-265.
[34] Stecker MS, Fan CM.Lymphangiography for Thoracic Duct Interventions[J]. Tech Vasc Interv Radiol, 2016, 19(4): 277-285.
[35] Pamarthi V, Stecker MS, Schenker MP, et al.Thoracic duct embolization and disruption for treatment of chylous effusions: experience with 105 patients[J]. J Vasc Interv Radiol, 2014, 25(9): 1398-1404.
[36] Paul S, Altorki NK, Port JL, et al.Surgical management of chylothorax[J]. Thorac Cardiovasc Surg, 2009, 57: 226-268.
[37] Epaud R, Dubern B, Larroquet M, et al.Therapeutic strategies for idiopathic chylothorax[J]. J Pediatr Surg, 2008, 43: 461-65.
[38] Gupta D, Ross K, Piacentino V 3rd, et al. Use of LeVeen pleuroperitoneal shunt for refractory high-volume chylothorax[J]. Ann Thorac Surg, 2004, 78(1): e9-12.
[39] Uchida S, Suzuki K, Hattori A, et al.Surgical intervention strategy for postoperative chylothorax after lung resection[J]. Surg Today, 2016, 46(2): 197-202.
[40] Matsuura Y, Ichinose J, Nakao M, et al.Recent fluorescence imaging technology applications of indocyanine green in general thoracic surgery[J]. Surg Today, 2020, 50(11): 1332-1342.
[41] Crucitti P, Mangiameli G, Petitti T, et al.Does prophylactic ligation of the thoracic duct reduce chylothorax rates in patients undergoing oesophagectomy? A systematic review and meta-analysis[J]. Eur J Cardiothorac Surg, 2016, 50(6): 1019-1024.
[42] Chen C, Wang Z, Hao J, et al.Chylothorax after Lung Cancer Surgery: A Key Factor Influencing Prognosis and Quality of Life[J]. Ann Thorac Cardiovasc Surg, 2020, 26(6): 303-310.
[43] Liu Z, Du M, Liang Y, et al.Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer[J]. Surg Today, 2020, 50(8): 881-888
[44] Arshava EV, Parekh KR.Thoracoscopic Thoracic Duct Ligation: How I Teach It[J]. Ann Thorac Surg, 2020, 109(5): 1330-1334.
[45] Jínek T, Adamčík L, Duda M, et al.Prophylactic ligation of the thoracic duct in the prevention of chylothorax after esophagectomy[J]. Rozhl Chir, 2018, 97(7): 328-334.
[46] Liu L, Gong L, Zhang M, Wu W.The effect of prophylactic thoracic duct ligation during esophagectomy on the incidence of chylothorax and survival of the patients: an updated review[J]. Postgrad Med, 2021, 133(3): 265-271.
[47] Li S, Wang Y, Zhou K, et al.Body surface area as a novel risk factor for chylothorax complicating video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer[J]. Thorac Cancer, 2018, 9(12): 1741-1753.
[48] An R, Xia S, Sun Y, et al.New application of direct lymphangiography in the diagnosis and treatment of chylothorax after lung cancer surgery: a case series[J]. Ann Palliat Med, 2021, 10(4):4768-4776.